![Michael Schultz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Michael Schultz served as a Member-Supervisory Board at MOLOGEN AG from 2018 to 2020.
He also worked as the President & Chief Scientific Officer at Chembridge Research Laboratories, Inc.
Former positions of Michael Schultz
| Companies | Position | End |
|---|---|---|
| MOLOGEN AG | Director/Board Member | 30/07/2020 |
Chembridge Research Laboratories, Inc.
 Chembridge Research Laboratories, Inc. Medical DistributorsDistribution Services Discovers molecule drugs | President | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
MOLOGEN AG
 MOLOGEN AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for the treatment of infectious diseases | Health Technology |
Chembridge Research Laboratories, Inc.
Chembridge Research Laboratories, Inc. Medical DistributorsDistribution Services Discovers molecule drugs | Distribution Services |
- Stock Market
- Insiders
- Michael Schultz
